Vassilios A. Dimitropoulos
Expertise in
34
conditions

Dr. Vassilios A. Dimitropoulos

Dermatology
2900 Niles Road, 
Saint Joseph, MI 
On Staff At
Accepting New Patients
Offers Telehealth
25 Years of Experience
Expertise in
34
conditions
2900 Niles Road, 
Saint Joseph, MI 

Overview

Vassilios Dimitropoulos is a Dermatologist in Saint Joseph, Michigan. Dr. Dimitropoulos has been practicing medicine for over 25 years is highly rated in 34 conditions, according to our data. His top areas of expertise are Sunburn, Trichoepithelioma, Multiple Familial Trichoepithelioma, and Syringoma. Dr. Dimitropoulos is currently accepting new patients.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Rush Medical College Of Rush University Medical Center, 2001

Residency

University of Michigan Hospitals and Health Centers

Specialties

Dermatology

Licenses

Dermatology in IL

Board Certifications

American Board Of Dermatology
American Board Of Dermatology

Fellowships

Rush University Medical Center

Hospital Affiliations

Corewell Health Lakeland Hospitals
Corewell Health Watervliet Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

St Joseph Dermatology and Vein Clinic
2900 Niles Road, Saint Joseph, MI 49085

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 7 Less Clinical Trials

4 Total Publications

Reasons behind the ink.
Reasons behind the ink.
Journal: Cutis
Published: January 02, 2017
Similar Doctors
Joan Guitart
Expertise in
16
conditions
Dr. Joan Guitart
Dermatology
Expertise in
16
conditions
Dr. Joan Guitart
Dermatology
676 N St Clair St Ste 1600, Arkes Pavilion, 
Chicago, IL 
 (60.1 miles away)
312-695-8106
Experience:
43+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Joan Guitart is a Dermatologist in Chicago, Illinois. Dr. Guitart has been practicing medicine for over 43 years is highly rated in 16 conditions, according to our data. His top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Lymphomatoid Papulosis.

Pedram Gerami
Expertise in
12
conditions
Dr. Pedram Gerami
Dermatology
Expertise in
12
conditions
Dr. Pedram Gerami
Dermatology
676 N St Clair St Ste 1600, Arkes Pavilion, 
Chicago, IL 
 (60.1 miles away)
312-695-8106
Experience:
25+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Pedram Gerami is a Dermatologist in Chicago, Illinois. Dr. Gerami has been practicing medicine for over 25 years is highly rated in 12 conditions, according to our data. His top areas of expertise are Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Tieche-Jadassohn Nevus, and Giant Congenital Melanocytic Nevus.

Peter A. Lio
Expertise in
8
conditions
Dr. Peter A. Lio
Dermatology
Expertise in
8
conditions
Dr. Peter A. Lio
Dermatology

Medical Dermatology Associates Of Chicago, SC

363 W Erie St, 
Chicago, IL 
 (61.4 miles away)
312-995-1955
Languages Spoken:
English, Spanish
See accepted insurances
Offers Telehealth

Peter Lio is a Dermatologist in Chicago, Illinois. Dr. Lio is highly rated in 8 conditions, according to our data. His top areas of expertise are Atopic Dermatitis, Perioral Dermatitis, Rosacea, and Contact Dermatitis.

Frequently Asked Questions about Dr. Vassilios A. Dimitropoulos

How do I make an appointment with Dr. Vassilios A. Dimitropoulos?

You can book an appointment with Dr. Vassilios A. Dimitropoulos by calling their office at 269-428-5199. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Vassilios A. Dimitropoulos a top-rated expert for Sunburn?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Vassilios A. Dimitropoulos is classified as an Distinguished expert for Sunburn, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Vassilios A. Dimitropoulos specialize in?

While Dr. Vassilios A. Dimitropoulos is a Dermatology, they have specific expertise in Sunburn, Trichoepithelioma, and Multiple Familial Trichoepithelioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Vassilios A. Dimitropoulos participate in research or clinical trials?

Yes. Dr. Vassilios A. Dimitropoulos has published 4 articles and abstracts on conditions like Sunburn. You can view a list of Dr. Vassilios A. Dimitropoulos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Vassilios A. Dimitropoulos accept my insurance?

Dr. Vassilios A. Dimitropoulos accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 269-428-5199 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dimitropoulos's expertise for a condition
ConditionClose
    View All 28 Advanced Conditions
    View All 57 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile